Neutrophil-To-Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community-Acquired Pneumonia
Overview
Authors
Affiliations
Objectives: To explore the performance of the neutrophil-to-lymphocyte ratio (NLR), an index of systemic inflammation that predicts prognosis of several diseases, in a cohort of elderly adults with community-acquired pneumonia (CAP).
Design: Prospective clinical study from January 2014 to July 2016.
Setting: Unit of Internal Medicine, University of Catania, Catania, Italy.
Participants: Elderly adults admitted for CAP (N = 195).
Measurements: Clinical diagnosis of CAP was defined as the presence of a new infiltrate on plain chest radiography or chest computed tomography associated with one or more suggestive clinical features such as dyspnea, hypo- or hyperthermia, cough, sputum production, tachypnea (respiration rate >20 breaths per minute), altered breath sounds on physical examination, hypoxemia (partial pressure of oxygen <60 mmHg), leukocytosis (white blood cell count >10,000/μL). Clinical examination, traditional tests such as Pneumonia Severity Index (PSI); Confusion, Urea, Respiratory rate, Blood pressure, aged 65 and older (CURB-65), and NLR were evaluated at admission. The accuracy and predictive value for 30-day mortality of traditional scores and NLR were compared.
Results: NLR predicted 30-day mortality (P < .001) and performed better than PSI (P < .05), CURB-65, C-reactive protein, and white blood cell count (P < .001) to predict prognosis. No deaths occurred in participants with a NLR of less than 11.12. Thirty-day mortality was 30% in those with a NLR between 11.12% and 13.4% and 50% in those with a NLR between 13.4 and 28.3. All participants with a NLR greater than 28.3 died within 30 days.
Conclusions: These results would encourage early discharge of individuals with a NLR of less than 11.12, short-term in-hospital care for those with a NLR between 11.12 and 13.4, middle-term hospitalization for those with a NLR between 13.4 and 28.3, and admission to a respiratory intensive care unit for those with a NLR greater than 28.3.
Calis A, Karaboga B, Uzer F, Kaplan N, Karaca M, Gedik R J Clin Med. 2025; 14(3).
PMID: 39941399 PMC: 11818467. DOI: 10.3390/jcm14030728.
Prediction of tuberculosis-specific mortality for older adult patients with pulmonary tuberculosis.
Wang S, Gu R, Ren P, Chen Y, Wu D, Li L Front Public Health. 2025; 12:1515867.
PMID: 39882120 PMC: 11774867. DOI: 10.3389/fpubh.2024.1515867.
Guzel E, Mete B, Baydar Toprak O, Ates Ayhan N, Firat A, Bulut Y Int J Immunopathol Pharmacol. 2024; 38:3946320241303331.
PMID: 39699047 PMC: 11660357. DOI: 10.1177/03946320241303331.
Tang Y, Yang D, Zhang J, Shen L, Xie Q, Luo Q Eur J Med Res. 2024; 29(1):591.
PMID: 39696671 PMC: 11657700. DOI: 10.1186/s40001-024-02195-7.
Sharma Y, Mangoni A, Horwood C, Thompson C Nutrients. 2024; 16(23).
PMID: 39683403 PMC: 11643628. DOI: 10.3390/nu16234009.